MedPath

sublingual misoprostol 25 µg and oral misoprostol 50 µg on reducing post-term pregnancy

Early Phase 1
Recruiting
Conditions
termination of pregnancy.
Medical abortion
Registration Number
IRCT20191208045653N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
140
Inclusion Criteria

Maximum gestational age of 40 weeks
pregnant women
Prime Grave
Single pregnancy
Cephalic display
Having normal amniotic fluid (AFI greater than or equal to 5 cm)
Bishop Score less than 8
Maternal age between 18 and 40 years

Exclusion Criteria

History of medical and midwifery disease
Diabetes
Preeclampsia
History of stillbirth
Opt out of the study
Improper use of medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of Cervical Preparation to Delivery. Timepoint: After Intervention. Method of measurement: Time.
Secondary Outcome Measures
NameTimeMethod
Fetal heart monitoring. Timepoint: After intervention. Method of measurement: Cardiac monitoring device.
© Copyright 2025. All Rights Reserved by MedPath